Joel O. Melby

850 citations
11 papers · 632 indexed · h-index 10
Topics
Microbial Natural Products and Biosynthesis (8 papers)Genomics and Phylogenetic Studies (5 papers)Chemical Synthesis and Analysis (3 papers)

In The Last Decade

Joel O. Melby

11 papers receiving 629 citations

Peers

Joel O. Melby
Comparison fields: 5 of 55
  • Molecular Biology 529
  • Pharmacology 416
  • Organic Chemistry 137
  • Microbiology 63
  • Biotechnology 61
Replace Manuel A. Ortega with:
Manuel A. Ortega United States
Matthias Strieker Germany
D. John Lee United States
Adam J. DiCaprio United States
Yanxiang Shi United States
Timo Schmiederer Germany
Natalia M. Vior United Kingdom
Brandon J. Burkhart United States
Dandan Chen China
Joel O. Melby relative to Manuel A. Ortega United States Manuel A. Ortega's profile →
Citations per field
00.5×1.5×
Manuel A. Ortega · 1×
Citations per year

Countries citing papers authored by Joel O. Melby

Since Specialization
Citations

This map shows the geographic impact of Joel O. Melby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel O. Melby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel O. Melby more than expected).

Fields of papers citing papers by Joel O. Melby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel O. Melby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel O. Melby. The network helps show where Joel O. Melby may publish in the future.

Co-authorship network of co-authors of Joel O. Melby

This figure shows the co-authorship network connecting the top 25 collaborators of Joel O. Melby. A scholar is included among the top collaborators of Joel O. Melby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel O. Melby. Joel O. Melby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 11
2 77
3 53
4 58
5 37
6 39
7 50
8 104
9 49
10 149
11 5

About Joel O. Melby

Joel O. Melby is a scholar working on Pharmacology, Microbiology and Molecular Biology, having authored 11 papers that have together received 632 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (8 papers), Genomics and Phylogenetic Studies (5 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Pharmacology (416 citations), Microbiology (63 citations) and Molecular Biology (529 citations). Joel O. Melby has collaborated with scholars based in United States, Czechia and Russia. Frequent co-authors include Douglas A. Mitchell, Kyle L. Dunbar, Jonathan I. Tietz, Patricia M. Blair, Mikhail Metelev, Konstantin Severinov, Lingyang Zhu, James R. Doroghazi, Courtney Cox and Qi Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026